Difference between revisions of "Part:BBa K5137000"
| (4 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
<partinfo>BBa_K5137000 short</partinfo> | <partinfo>BBa_K5137000 short</partinfo> | ||
| − | + | ===Introduction=== | |
| − | + | This tumor homing peptide, known as p160, has been adopted from Tong et al., 2022. | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Latest revision as of 08:01, 2 October 2024
Targeting Part
Introduction
This tumor homing peptide, known as p160, has been adopted from Tong et al., 2022.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]